Form4insider filings, from the source

SEC Form 4 · accession 0001182489-17-000447

Nexvet Biopharma plc · NVET

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
FARALLON PARTNERS L L C/CA
10% Owner · Other
Michael B. Fisch
10% Owner · Other
Akubra Investors, LLC
10% Owner · Other
Bushranger Funding, LLC
10% Owner · Other
Ute Holdings, LLC
10% Owner · Other
NGP, L.L.C.
10% Owner · Other
Farallon AA G.P., L.L.C.
10% Owner · Other
Philip D Dreyfuss
10% Owner · Other
Period of report
Jul 31, 2017
Accepted (ET)
Aug 2, 2017 · 3:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF14,F1,F2,F3Jul 31, 2017U833,845$6.72D0D
Ordinary SharesF14,F1,F2,F4Jul 31, 2017U899,268$6.72D0D
Ordinary SharesF14,F1,F2,F5Jul 31, 2017U915,583$6.72D0D
Ordinary SharesF14,F1,F2,F3,F7,F8Jul 31, 2017U122,006$6.72D0ISee Footnotes
Ordinary SharesF14,F1,F2,F4,F9Jul 31, 2017U249,462$6.72D0ISee Footnotes
Ordinary SharesF14,F1,F2,F5,F10Jul 31, 2017U209,577$6.72D0ISee Footnotes
Ordinary SharesF14,F1,F2,F11Jul 31, 2017U2,067,651$6.72D0ISee Footnotes
Ordinary SharesF14,F1,F2,F6,F12,F13Jul 31, 2017U2,648,696$6.72D0ISee Footnotes

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses